Login or sign up
For business

Hephaistos-pharma

4.2· 10 reviews
Average ratingGreat
4.2/ 5

Based on 10 reviews

540%
440%
320%
20%
10%
Ask AI

Questions about Hephaistos-pharma

Based on 10 reviews, listing data and website checks · updated 7 days ago

What is Hephaistos-pharma?

Hephaistos Pharma is a biopharmaceutical company developing 3rd generation innate immune boosters, specifically a lead drug-candidate called HEPHA440, designed to convert myeloid-rich tumors into immunotherapy-responsive tumors for front-line cancer therapy.

What is the primary goal of their lead drug-candidate HEPHA440?

The company is advancing a next-generation TLR4 agonist with a high therapeutic index, aiming to provide effective and safe cancer therapy by unlocking immunity in patients with specific tumor profiles.

When is the lead drug-candidate expected to enter clinical trials?

Hephaistos Pharma is scheduled to enter clinical trials in 2028, marking a key milestone in their development timeline for this new immunotherapy approach.

Who are the key people leading the company?

The company's team includes scientific founders Frederic Caroff, Frederique Brune, Stephan Braun, Jérôme Kerzerho, and Simon Pico, alongside board members like Dr. David Sourdive and Florian Denis.

Where is Hephaistos Pharma based?

The company is located in France, as indicated by its country code FR and the French names of its team members and advisors.

How do customers describe the company's website?

The company's website, hephaistos-pharma.com, is described by reviewers as user-friendly, easy to navigate, and easy to use for ordering products.

What aspects of the customer experience do reviewers highlight?

Reviewers consistently praise the fast and prompt delivery of products, noting that the ordering process is smooth and the overall experience is positive.

How do customers describe the quality of the products?

The company's products are described as high-quality, excellent, and top-quality, with customers expressing satisfaction and happiness with their purchases.

What safety profile has been demonstrated for HEPHA440?

The company has a broad therapeutic window predicting safe and efficacious systemic administration in humans, according to their own website.

Where can more information about the company be found online?

The company's social profile is available on LinkedIn, providing additional information about their organization.

Is Hephaistos-pharma on social media?

Hephaistos-pharma has official profiles on Linkedin.

AI-generated from reviews on this page. Verify anything important with the company directly.

News

No news yet. This is where the business shares its own updates and press.

Photos

No photos yet. Photos shared by reviewers will show up here.

Widgets

Boost your business trust by displaying a widget on your website — a simple way to convert your visitors into customers.

Get the widget for your site →

About Hephaistos-pharma

Categories
Biotechnology